Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Stem Cell Culture01:17

Stem Cell Culture

4.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Absence of GDF15 Aggravates Pressure Overload-Induced Cardiac Remodelling in Mice Hallmarked by Perivascular Fibrosis and Signs of Endothelial-to-Mesenchymal Transition.

International journal of molecular sciences·2026
Same author

Advances in Living Myocardial Slice Technology for Heart Failure Research.

Current heart failure reports·2026
Same author

A novel mouse model for cardiovascular-kidney-metabolic syndrome: Bridging metabolic, renal and cardiac dysfunction.

Molecular metabolism·2026
Same author

Biological tissue engineering for Fontan failure using decellularized extracellular matrix: a systematic review.

Journal of translational medicine·2026
Same author

BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial Hypertension.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitment.

Nature communications·2025

Related Experiment Video

Updated: Apr 27, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

9.9K

A straightforward guide to the basic science behind cardiovascular cell-based therapies.

Marie-José Goumans1, Janita A Maring1, Anke M Smits1

  • 1Department of Molecular Cell Biology and Center for Biomedical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Heart (British Cardiac Society)
|July 5, 2014
PubMed
Summary
This summary is machine-generated.

Cell-based therapy for myocardial infarction (MI) shows safety but limited cardiac function improvement. Understanding different stem cell types

Keywords:
Basic ScienceMyocardial Ischaemia and Infarction (IHD)

More Related Videos

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

13.1K
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

6.3K

Related Experiment Videos

Last Updated: Apr 27, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

9.9K
Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

13.1K
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

6.3K

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Cell-based therapy has been explored for myocardial infarction (MI) treatment for over a decade.
  • Early clinical trials utilized various stem cells like bone marrow mononuclear cells (BM-MNC), mesenchymal stem cells (MSC), and cardiac progenitor cells (CPC).
  • The initial hypothesis focused on stem cell differentiation into cardiac tissue and enhancement of wound healing post-MI.

Purpose of the Study:

  • To evaluate the efficacy of different stem cell types in cardiac repair after myocardial infarction.
  • To understand the distinct capabilities of various cell populations in addressing post-MI wound healing.
  • To inform the design of optimized cell-based therapeutic strategies for MI.

Main Methods:

  • Review of preclinical and clinical trial data on stem cell therapy for MI.
  • Analysis of the mechanisms by which different stem cell types influence cardiac wound healing.
  • Comparative assessment of the regenerative potential of BM-MNC, MSC, and CPC.

Main Results:

  • Clinical trials demonstrated the safety of cell-based therapies for MI.
  • A relatively modest improvement in cardiac function was observed across studies.
  • Each cell type exhibits unique properties influencing cardiac repair post-MI.

Conclusions:

  • Current cell-based therapies for MI, while safe, offer limited functional recovery.
  • Further research into the specific behaviors and reparative abilities of different stem cell populations is crucial.
  • Optimizing cell-based therapy requires a deeper understanding of cell-type specific contributions to post-MI wound healing.